Innovation | Ophthalmology Innovation Source

Ophthalmic Innovation 2015 – “A View from the AAO”

Participant: David Parke, MD II Dr. Parke is CEO of the American Academy of Ophthalmology. Prior to assuming this role, Dr. Parke served as president and CEO of the Dean McGee Eye Institute and Chair of the Department of Ophthalmology at the University of Oklahoma. View Full Profile

Ophthalmic Innovation 2015 – “A View from the NEI”

Participant: Paul A. Sieving, MD, PhD Dr. Sieving became Director of the National Eye Institute after serving as the Paul R. Lichter Professor of Ophthalmic Genetics and founding director of the Center for Retinal and Macular Degeneration at the University of Michigan. View Full Profile

Alcon – Google Innovation: Visions of Ophthalmology in 2020

Participants: William J. Link, PhD Prior to Versant, Bill was a general partner at Brentwood Venture Capital. He founded, and served as chairman and CEO of Chiron Vision. Chiron Vision was sold to Bausch and Lomb in 1997. View Full Profile Laurent Attias Laurent Attias is currently Senior Vice President, Head of Strategy, BD&L and…

Thinking About Market Cycles & Growth in the Ophthalmology Sector

A panel of Wall Street analysts offer their insights on the future performance of the public markets, including ophthalmology stocks at OIS@AAO in Las Vegas. Participants: Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham, currently a Partner, joined Clarus in 2006 with more than 20 years of experience in the biomedical and biopharmaceutical sectors.…

Masters of the Universe

Participants: Jim Mazzo James V. Mazzo is Global President for Carl Zeiss Meditec’s Strategic Business Unit Ophthalmic Devices, which includes Ophthalmic Diagnostics, Surgical Ophthalmology and Refractive Lasers. View Full Profile Jeff George Jeff was appointed to lead Alcon in May 2014. As the global leader in eye care, Alcon provides innovative products that enhance quality…

International Biomedical Devices

IBMD is an early-stage medical device company focused in ophthalmology innovations. The company is leading the emerging, non-laser based, precision capsulotomy category through the development of a unique capsulotomy technology. ApertureCTC™ represents a considerable improvement to traditional surgical techniques by ensuring safe and precise capsulotomies and predictable outcomes for patients. www.aperturectc.com

Mati Therapeutics

Mati is developing a punctal plug drug delivery technology for sustained drug delivery using an “L-shaped” design to deliver medications to the canalicular space. Insertion is via slit lamp, with only the initial procedure requiring patient dilation. The company’s device separates itself from others in that there is a one-directional drug flow out of the…

Mynosys Cellular Devices

Zepto is an innovative disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate and creates a reproducible capsulotomy that is quick, safe, and affordable. Zepto consists of a silicon suction cup, a nitinol capsulotomy cutting element and an incision finder/push-rod system. The system works by stretching…

Saunders Speaks to Allergan’s Innovative Culture

Prior to the announcement of the Pfizer-Allergan combination, Allergan CEO and President Brent Saunders spoke with OISTV about how the pharma industry finds and foster innovation, particularly in ophthalmology. Under Saunders, Allergan works hard to “support” rather than “assimilate” new technologies like Oculeve’s neurostimulation-based treatment for Dry Eye. As President and COO of the new…

A Rundown of a Record-setting OIS

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 066″] The Ophthalmology Innovation Summit hit it big in Las Vegas prior to the industry’s American Academy of Ophthalmology Annual Meeting. With close to 1,000 registered attendees, OIS@AAO brought innovators together with both public and private investors as well as corpo-rate leaders of our dynamic sector. OIS Podcast walks through the…

Brent Saunders, President & CEO of Allergan

Brent Saunders delivers a data-packed presentation about the state of innovation in the life sciences industry and discusses where ophthalmology fits into Allergan’s future. Participant: Brent Saunders Brent Saunders has served as CEO and President of Allergan, formerly Actavis, since July 1, 2014. Previously, Mr. Saunders served as CEO and President of Forest Laboratories from…

Transcend Medical

The year 2015 represented a milestone for Transcend Medical – it completed a milestone study and filed a Premarket Approval for a minimally invasive glaucoma surgery (MIGS) device, the CyPass Micro-Stent. The CyPass is a next-generation device designed to enhance aqueous outflow to the suprachoroidal space by being placed in the supraciliary space (an ab…